Skip to main navigation
Skip to search
Skip to main content
WashU Medicine Research Profiles Home
Help & FAQ
Link opens in a new tab
Search content at WashU Medicine Research Profiles
Home
Profiles
Departments, Divisions and Centers
Research output
Advances in positron emission tomographic imaging of lung cancer
Delphine L. Chen
,
Farrokh Dehdashti
Division of Nuclear Medicine
Institute of Clinical and Translational Sciences (ICTS)
Siteman Cancer Center
Department of Radiology
Research output
:
Contribution to journal
›
Article
›
peer-review
25
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Advances in positron emission tomographic imaging of lung cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Positron Emission Tomography
100%
Lung Cancer
100%
Fluorodeoxyglucose
50%
Tumor
25%
Cell Membrane
25%
Thymidine Analogs
25%
Clinical Management
25%
Malignancy
25%
Malignant Transformation
25%
Cellular Processes
25%
18F-fluorodeoxyglucose (18F-FDG)
25%
Non-small Cell Lung Cancer (NSCLC)
25%
Oncologic
25%
Patient Management
25%
DNA Synthesis
25%
False-positive Results
25%
Inflammatory Lesions
25%
Methionine
25%
Choline
25%
Conventional Therapy
25%
Diacetyl
25%
Tumor Glucose Metabolism
25%
Metabolism in Vivo
25%
New Tracer
25%
18F-fluorothymidine
25%
Positron Emission Tomography Tracers
25%
Fluoromisonidazole
25%
Membrane Synthesis
25%
Tumor Hypoxia Imaging
25%
Medicine and Dentistry
Positron Emission Tomography
100%
Lung Cancer
100%
Cancer
50%
Fluorodeoxyglucose
50%
Fluorine-18
50%
Serositis
25%
Neoplasm
25%
Thymidine
25%
Clinical Study
25%
Malignant Transformation
25%
Non Small Cell Lung Cancer
25%
Tumor
25%
Glucose Metabolism
25%
Fluorodeoxyglucose F 18
25%
Cell Membrane
25%
Clinical Management
25%
False Positive Result
25%
Carbon 11
25%
2,3 Butanedione
25%
DNA Synthesis
25%
Methionine
25%
Tumor Hypoxia
25%
Choline
25%
1 Fluoro 3 (2 Nitro 1 Imidazolyl) 2 Propanol
25%